The global Oral Vaccine for Human market was valued at 2583 million in 2024 and is projected to reach US$ 3881 million by 2031, at a CAGR of 6.1% during the forecast period.
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.
The oral vaccine market is driven by the growing demand for convenient and needle-free vaccination options, especially in pediatric and developing regions. Oral vaccines offer advantages like ease of administration, increased patient compliance, and simplified logistics, making them suitable for mass vaccination programs and reaching remote areas with limited healthcare infrastructure. The potential for improved vaccine stability and reduced production costs further contribute to market growth. However, the market also faces challenges, such as the need for enhanced vaccine stability to withstand gastrointestinal conditions and ensuring consistent efficacy across diverse populations. Additionally, regulatory complexities and the requirement for stringent safety and efficacy data can pose obstacles for oral vaccine manufacturers. To succeed in this market, companies must focus on innovative vaccine delivery technologies, conduct robust clinical trials, collaborate with global health agencies, and address public perception and trust in oral vaccine safety and effectiveness.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Vaccine for Human manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Oral Vaccine for Human, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccine for Human. This report contains market size and forecasts of Oral Vaccine for Human in global, including the following market information:
Global Oral Vaccine for Human market revenue, 2020-2025, 2026-2031, ($ millions)
Global Oral Vaccine for Human market sales, 2020-2025, 2026-2031, (K Units)
Global top five Oral Vaccine for Human companies in 2024 (%)
Total Market by Segment:
Global Oral Vaccine for Human market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Oral Vaccine for Human market segment percentages, by Type, 2024 (%)
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Global Oral Vaccine for Human market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Oral Vaccine for Human market segment percentages, by Application, 2024 (%)
Public
Private
Global Oral Vaccine for Human market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Oral Vaccine for Human market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Vaccine for Human revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Oral Vaccine for Human revenues share in global market, 2024 (%)
Key companies Oral Vaccine for Human sales in global market, 2020-2025 (estimated), (K Units)
Key companies Oral Vaccine for Human sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Vaccine for Human, market overview.
Chapter 2: Global Oral Vaccine for Human market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Vaccine for Human manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccine for Human in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Vaccine for Human capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Oral Vaccine for Human Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Oral Vaccine for Human Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Vaccine for Human Overall Market Size
2.1 Global Oral Vaccine for Human Market Size: 2024 VS 2031
2.2 Global Oral Vaccine for Human Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Oral Vaccine for Human Sales: 2020-2031
3 Company Landscape
3.1 Top Oral Vaccine for Human Players in Global Market
3.2 Top Global Oral Vaccine for Human Companies Ranked by Revenue
3.3 Global Oral Vaccine for Human Revenue by Companies
3.4 Global Oral Vaccine for Human Sales by Companies
3.5 Global Oral Vaccine for Human Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Oral Vaccine for Human Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Oral Vaccine for Human Product Type
3.8 Tier 1, Tier 2, and Tier 3 Oral Vaccine for Human Players in Global Market
3.8.1 List of Global Tier 1 Oral Vaccine for Human Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Vaccine for Human Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Oral Vaccine for Human Market Size Markets, 2024 & 2031
4.1.2 Rotavirus Vaccine
4.1.3 Cholera Vaccine
4.1.4 Oral Polio Vaccine
4.1.5 Other
4.2 Segment by Type - Global Oral Vaccine for Human Revenue & Forecasts
4.2.1 Segment by Type - Global Oral Vaccine for Human Revenue, 2020-2025
4.2.2 Segment by Type - Global Oral Vaccine for Human Revenue, 2026-2031
4.2.3 Segment by Type - Global Oral Vaccine for Human Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Oral Vaccine for Human Sales & Forecasts
4.3.1 Segment by Type - Global Oral Vaccine for Human Sales, 2020-2025
4.3.2 Segment by Type - Global Oral Vaccine for Human Sales, 2026-2031
4.3.3 Segment by Type - Global Oral Vaccine for Human Sales Market Share, 2020-2031
4.4 Segment by Type - Global Oral Vaccine for Human Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Oral Vaccine for Human Market Size, 2024 & 2031
5.1.2 Public
5.1.3 Private
5.2 Segment by Application - Global Oral Vaccine for Human Revenue & Forecasts
5.2.1 Segment by Application - Global Oral Vaccine for Human Revenue, 2020-2025
5.2.2 Segment by Application - Global Oral Vaccine for Human Revenue, 2026-2031
5.2.3 Segment by Application - Global Oral Vaccine for Human Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Oral Vaccine for Human Sales & Forecasts
5.3.1 Segment by Application - Global Oral Vaccine for Human Sales, 2020-2025
5.3.2 Segment by Application - Global Oral Vaccine for Human Sales, 2026-2031
5.3.3 Segment by Application - Global Oral Vaccine for Human Sales Market Share, 2020-2031
5.4 Segment by Application - Global Oral Vaccine for Human Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Oral Vaccine for Human Market Size, 2024 & 2031
6.2 By Region - Global Oral Vaccine for Human Revenue & Forecasts
6.2.1 By Region - Global Oral Vaccine for Human Revenue, 2020-2025
6.2.2 By Region - Global Oral Vaccine for Human Revenue, 2026-2031
6.2.3 By Region - Global Oral Vaccine for Human Revenue Market Share, 2020-2031
6.3 By Region - Global Oral Vaccine for Human Sales & Forecasts
6.3.1 By Region - Global Oral Vaccine for Human Sales, 2020-2025
6.3.2 By Region - Global Oral Vaccine for Human Sales, 2026-2031
6.3.3 By Region - Global Oral Vaccine for Human Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Oral Vaccine for Human Revenue, 2020-2031
6.4.2 By Country - North America Oral Vaccine for Human Sales, 2020-2031
6.4.3 United States Oral Vaccine for Human Market Size, 2020-2031
6.4.4 Canada Oral Vaccine for Human Market Size, 2020-2031
6.4.5 Mexico Oral Vaccine for Human Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Oral Vaccine for Human Revenue, 2020-2031
6.5.2 By Country - Europe Oral Vaccine for Human Sales, 2020-2031
6.5.3 Germany Oral Vaccine for Human Market Size, 2020-2031
6.5.4 France Oral Vaccine for Human Market Size, 2020-2031
6.5.5 U.K. Oral Vaccine for Human Market Size, 2020-2031
6.5.6 Italy Oral Vaccine for Human Market Size, 2020-2031
6.5.7 Russia Oral Vaccine for Human Market Size, 2020-2031
6.5.8 Nordic Countries Oral Vaccine for Human Market Size, 2020-2031
6.5.9 Benelux Oral Vaccine for Human Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Oral Vaccine for Human Revenue, 2020-2031
6.6.2 By Region - Asia Oral Vaccine for Human Sales, 2020-2031
6.6.3 China Oral Vaccine for Human Market Size, 2020-2031
6.6.4 Japan Oral Vaccine for Human Market Size, 2020-2031
6.6.5 South Korea Oral Vaccine for Human Market Size, 2020-2031
6.6.6 Southeast Asia Oral Vaccine for Human Market Size, 2020-2031
6.6.7 India Oral Vaccine for Human Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Oral Vaccine for Human Revenue, 2020-2031
6.7.2 By Country - South America Oral Vaccine for Human Sales, 2020-2031
6.7.3 Brazil Oral Vaccine for Human Market Size, 2020-2031
6.7.4 Argentina Oral Vaccine for Human Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Vaccine for Human Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Oral Vaccine for Human Sales, 2020-2031
6.8.3 Turkey Oral Vaccine for Human Market Size, 2020-2031
6.8.4 Israel Oral Vaccine for Human Market Size, 2020-2031
6.8.5 Saudi Arabia Oral Vaccine for Human Market Size, 2020-2031
6.8.6 UAE Oral Vaccine for Human Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Oral Vaccine for Human Major Product Offerings
7.1.4 Merck Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Oral Vaccine for Human Major Product Offerings
7.2.4 GSK Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Oral Vaccine for Human Major Product Offerings
7.3.4 Sanofi Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.3.5 Sanofi Key News & Latest Developments
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Oral Vaccine for Human Major Product Offerings
7.4.4 Lanzhou Institute Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.4.5 Lanzhou Institute Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Oral Vaccine for Human Major Product Offerings
7.5.4 Serum Institute Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.5.5 Serum Institute Key News & Latest Developments
7.6 Valneva
7.6.1 Valneva Company Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Oral Vaccine for Human Major Product Offerings
7.6.4 Valneva Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.6.5 Valneva Key News & Latest Developments
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Company Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Oral Vaccine for Human Major Product Offerings
7.7.4 Shanghai United Cell Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.7.5 Shanghai United Cell Key News & Latest Developments
7.8 Bibcol
7.8.1 Bibcol Company Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Oral Vaccine for Human Major Product Offerings
7.8.4 Bibcol Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.8.5 Bibcol Key News & Latest Developments
7.9 PaxVax
7.9.1 PaxVax Company Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Oral Vaccine for Human Major Product Offerings
7.9.4 PaxVax Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.9.5 PaxVax Key News & Latest Developments
7.10 Vabiotech
7.10.1 Vabiotech Company Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Oral Vaccine for Human Major Product Offerings
7.10.4 Vabiotech Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.10.5 Vabiotech Key News & Latest Developments
7.11 Tiantan Biological
7.11.1 Tiantan Biological Company Summary
7.11.2 Tiantan Biological Business Overview
7.11.3 Tiantan Biological Oral Vaccine for Human Major Product Offerings
7.11.4 Tiantan Biological Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.11.5 Tiantan Biological Key News & Latest Developments
7.12 EuBiologics
7.12.1 EuBiologics Company Summary
7.12.2 EuBiologics Business Overview
7.12.3 EuBiologics Oral Vaccine for Human Major Product Offerings
7.12.4 EuBiologics Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.12.5 EuBiologics Key News & Latest Developments
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Company Summary
7.13.2 Panacea Biotec Ltd Business Overview
7.13.3 Panacea Biotec Ltd Oral Vaccine for Human Major Product Offerings
7.13.4 Panacea Biotec Ltd Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.13.5 Panacea Biotec Ltd Key News & Latest Developments
7.14 Bio-Med
7.14.1 Bio-Med Company Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Oral Vaccine for Human Major Product Offerings
7.14.4 Bio-Med Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.14.5 Bio-Med Key News & Latest Developments
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Company Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales and Revenue in Global (2020-2025)
7.15.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Oral Vaccine for Human Production Capacity, Analysis
8.1 Global Oral Vaccine for Human Production Capacity, 2020-2031
8.2 Oral Vaccine for Human Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Vaccine for Human Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Vaccine for Human Supply Chain Analysis
10.1 Oral Vaccine for Human Industry Value Chain
10.2 Oral Vaccine for Human Upstream Market
10.3 Oral Vaccine for Human Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Vaccine for Human Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Oral Vaccine for Human in Global Market
Table 2. Top Oral Vaccine for Human Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Oral Vaccine for Human Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Oral Vaccine for Human Revenue Share by Companies, 2020-2025
Table 5. Global Oral Vaccine for Human Sales by Companies, (K Units), 2020-2025
Table 6. Global Oral Vaccine for Human Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Oral Vaccine for Human Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Oral Vaccine for Human Product Type
Table 9. List of Global Tier 1 Oral Vaccine for Human Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Vaccine for Human Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Oral Vaccine for Human Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Oral Vaccine for Human Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Oral Vaccine for Human Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Oral Vaccine for Human Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Oral Vaccine for Human Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Oral Vaccine for Human Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 21. By Region – Global Oral Vaccine for Human Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 25. By Region - Global Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 26. By Country - North America Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 29. By Country - North America Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 30. By Country - Europe Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 33. By Country - Europe Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 34. By Region - Asia Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 37. By Region - Asia Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 38. By Country - South America Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 41. By Country - South America Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Oral Vaccine for Human Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Oral Vaccine for Human Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Oral Vaccine for Human Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Oral Vaccine for Human Sales, (K Units), 2026-2031
Table 46. Merck Company Summary
Table 47. Merck Oral Vaccine for Human Product Offerings
Table 48. Merck Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Merck Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Oral Vaccine for Human Product Offerings
Table 52. GSK Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Oral Vaccine for Human Product Offerings
Table 56. Sanofi Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Sanofi Key News & Latest Developments
Table 58. Lanzhou Institute Company Summary
Table 59. Lanzhou Institute Oral Vaccine for Human Product Offerings
Table 60. Lanzhou Institute Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Lanzhou Institute Key News & Latest Developments
Table 62. Serum Institute Company Summary
Table 63. Serum Institute Oral Vaccine for Human Product Offerings
Table 64. Serum Institute Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Serum Institute Key News & Latest Developments
Table 66. Valneva Company Summary
Table 67. Valneva Oral Vaccine for Human Product Offerings
Table 68. Valneva Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Valneva Key News & Latest Developments
Table 70. Shanghai United Cell Company Summary
Table 71. Shanghai United Cell Oral Vaccine for Human Product Offerings
Table 72. Shanghai United Cell Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Shanghai United Cell Key News & Latest Developments
Table 74. Bibcol Company Summary
Table 75. Bibcol Oral Vaccine for Human Product Offerings
Table 76. Bibcol Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Bibcol Key News & Latest Developments
Table 78. PaxVax Company Summary
Table 79. PaxVax Oral Vaccine for Human Product Offerings
Table 80. PaxVax Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. PaxVax Key News & Latest Developments
Table 82. Vabiotech Company Summary
Table 83. Vabiotech Oral Vaccine for Human Product Offerings
Table 84. Vabiotech Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Vabiotech Key News & Latest Developments
Table 86. Tiantan Biological Company Summary
Table 87. Tiantan Biological Oral Vaccine for Human Product Offerings
Table 88. Tiantan Biological Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Tiantan Biological Key News & Latest Developments
Table 90. EuBiologics Company Summary
Table 91. EuBiologics Oral Vaccine for Human Product Offerings
Table 92. EuBiologics Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. EuBiologics Key News & Latest Developments
Table 94. Panacea Biotec Ltd Company Summary
Table 95. Panacea Biotec Ltd Oral Vaccine for Human Product Offerings
Table 96. Panacea Biotec Ltd Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Panacea Biotec Ltd Key News & Latest Developments
Table 98. Bio-Med Company Summary
Table 99. Bio-Med Oral Vaccine for Human Product Offerings
Table 100. Bio-Med Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Bio-Med Key News & Latest Developments
Table 102. Halfkin Bio-Pharmaceuticals Company Summary
Table 103. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product Offerings
Table 104. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 106. Oral Vaccine for Human Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 107. Global Oral Vaccine for Human Capacity Market Share of Key Manufacturers, 2023-2025
Table 108. Global Oral Vaccine for Human Production by Region, 2020-2025 (K Units)
Table 109. Global Oral Vaccine for Human Production by Region, 2026-2031 (K Units)
Table 110. Oral Vaccine for Human Market Opportunities & Trends in Global Market
Table 111. Oral Vaccine for Human Market Drivers in Global Market
Table 112. Oral Vaccine for Human Market Restraints in Global Market
Table 113. Oral Vaccine for Human Raw Materials
Table 114. Oral Vaccine for Human Raw Materials Suppliers in Global Market
Table 115. Typical Oral Vaccine for Human Downstream
Table 116. Oral Vaccine for Human Downstream Clients in Global Market
Table 117. Oral Vaccine for Human Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Vaccine for Human Product Picture
Figure 2. Oral Vaccine for Human Segment by Type in 2024
Figure 3. Oral Vaccine for Human Segment by Application in 2024
Figure 4. Global Oral Vaccine for Human Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Oral Vaccine for Human Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Oral Vaccine for Human Revenue: 2020-2031 (US$, Mn)
Figure 8. Oral Vaccine for Human Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Oral Vaccine for Human Revenue in 2024
Figure 10. Segment by Type – Global Oral Vaccine for Human Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Oral Vaccine for Human Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Oral Vaccine for Human Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Oral Vaccine for Human Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Oral Vaccine for Human Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Oral Vaccine for Human Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Oral Vaccine for Human Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Oral Vaccine for Human Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 21. By Region - Global Oral Vaccine for Human Sales Market Share, 2020-2031
Figure 22. By Country - North America Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 23. By Country - North America Oral Vaccine for Human Sales Market Share, 2020-2031
Figure 24. United States Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Oral Vaccine for Human Sales Market Share, 2020-2031
Figure 29. Germany Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 30. France Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Oral Vaccine for Human Sales Market Share, 2020-2031
Figure 38. China Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 42. India Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Oral Vaccine for Human Revenue Market Share, 2020-2031
Figure 44. By Country - South America Oral Vaccine for Human Sales, Market Share, 2020-2031
Figure 45. Brazil Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Oral Vaccine for Human Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Oral Vaccine for Human Sales, Market Share, 2020-2031
Figure 49. Turkey Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Oral Vaccine for Human Revenue, (US$, Mn), 2020-2031
Figure 53. Global Oral Vaccine for Human Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Oral Vaccine for Human by Region, 2024 VS 2031
Figure 55. Oral Vaccine for Human Industry Value Chain
Figure 56. Marketing Channels
